BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 36065535)

  • 1. Effects and mechanisms of polycyclic aromatic hydrocarbons in inflammatory skin diseases.
    Jin H; Lin Z; Pang T; Wu J; Zhao C; Zhang Y; Lei Y; Li Q; Yao X; Zhao M; Lu Q
    Sci Total Environ; 2024 May; 925():171492. PubMed ID: 38458465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl hydrocarbon receptor role in chronic inflammatory skin diseases: a narrative review.
    Dec M; Arasiewicz H
    Postepy Dermatol Alergol; 2024 Feb; 41(1):9-19. PubMed ID: 38533374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the aryl hydrocarbon receptor as a strategy to expand the therapeutic armamentarium in atopic dermatitis.
    Eichenfield LF; Silverberg JI; Hebert AA; Boguniewicz M
    J Dermatolog Treat; 2024 Dec; 35(1):2300354. PubMed ID: 38213229
    [No Abstract]   [Full Text] [Related]  

  • 4. Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review.
    Silverberg JI; Boguniewicz M; Quintana FJ; Clark RA; Gross L; Hirano I; Tallman AM; Brown PM; Fredericks D; Rubenstein DS; McHale KA
    J Allergy Clin Immunol; 2023 Dec; ():. PubMed ID: 38154665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Air pollution and skin diseases: A comprehensive evaluation of the associated mechanism.
    Gu X; Li Z; Su J
    Ecotoxicol Environ Saf; 2024 Jun; 278():116429. PubMed ID: 38718731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tension as a key factor in skin responses to pollution.
    Pambianchi E; Hagenberg Z; Pecorelli A; Pasqui A; Therrien JP; Valacchi G
    Sci Rep; 2023 Sep; 13(1):16013. PubMed ID: 37749125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting New Approach Methodologies (NAMs) for research on skin color changes in response to environmental stress factors: tobacco and air pollution.
    Bouchard KV; Costin GE
    Front Toxicol; 2023; 5():1256399. PubMed ID: 37886123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Therapeutic Aryl Hydrocarbon Receptor-Modulating Agent Tapinarof Regulates SEMA3A Expression in Human Keratinocytes through NRF2.
    Tsuji G; Yumine A; Yamamura K; Takemura M; Kido-Nakahara M; Ito T; Nakahara T
    J Invest Dermatol; 2024 Mar; 144(3):710-713.e8. PubMed ID: 37838333
    [No Abstract]   [Full Text] [Related]  

  • 9. Environmental Air Pollutants Affecting Skin Functions with Systemic Implications.
    Bocheva G; Slominski RM; Slominski AT
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world PM extracts differentially enhance Th17 differentiation and activate the aryl hydrocarbon receptor (AHR).
    O'Driscoll CA; Gallo ME; Fechner JH; Schauer JJ; Mezrich JD
    Toxicology; 2019 Feb; 414():14-26. PubMed ID: 30611761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Aryl Hydrocarbon Receptor as an Immune-Modulator of Atmospheric Particulate Matter-Mediated Autoimmunity.
    O'Driscoll CA; Mezrich JD
    Front Immunol; 2018; 9():2833. PubMed ID: 30574142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Aryl Hydrocarbon Receptor Activation in Inflammatory Chronic Skin Diseases.
    Napolitano M; Fabbrocini G; Martora F; Picone V; Morelli P; Patruno C
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aryl hydrocarbon receptor pathway plays a central role in the cutaneous response to pollutants.
    Guillon C; Meziani M; Abdelli S; Sigaudo Roussel D; Bonod C; Nosbaum A
    Eur J Dermatol; 2022 May; 32(3):305-311. PubMed ID: 36065535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diosmin restores the skin barrier by targeting the aryl hydrocarbon receptor in atopic dermatitis.
    Lee J; Song KM; Jung CH
    Phytomedicine; 2021 Jan; 81():153418. PubMed ID: 33302042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin.
    Hidaka T; Ogawa E; Kobayashi EH; Suzuki T; Funayama R; Nagashima T; Fujimura T; Aiba S; Nakayama K; Okuyama R; Yamamoto M
    Nat Immunol; 2017 Jan; 18(1):64-73. PubMed ID: 27869817
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.